Roman Grunt, CEO of Quinta Analytica, gives us an overview of the activities of how the Czech firm has managed to attract customers across the country and beyond by positioning itself as the one-stop-shop for both the clinical and analytical aspects of clinical research. He also explains how Quinta Analytica is entering the field of first-in-human studies and receiving increased interest from Chinese partners.
We offer much greater flexibility [than larger firms]; as a small company there is direct contact with the project’s leaders and management and that allows us to significantly reduce timelines in delivering comprehensive results
